Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: Pooled analysis from EPIC, EPILOG and epistent trials

Leslie Cho, Eric J. Topol, Craig Balog, Joanne M. Foody, Joan E. Booth, Catherine Cabot, Neal S. Kleiman, James E. Tcheng, Robert Califf, A. Michael Lincoff

Research output: Contribution to journalArticlepeer-review

130 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: Pooled analysis from EPIC, EPILOG and epistent trials'. Together they form a unique fingerprint.

Medicine & Life Sciences